By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Genetics today said that it has regained compliance with the Nasdaq Capital Market's rule covering the minimum market value of listed securities.

The Los Angeles-based molecular diagnostics developer said that it was notified by Nasdaq on Feb. 16 that it had regained compliance and the "delisting matter is now closed."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.